PT3813832T - Compostos para utilização na prevenção ou tratamento de cancro - Google Patents
Compostos para utilização na prevenção ou tratamento de cancroInfo
- Publication number
- PT3813832T PT3813832T PT197335201T PT19733520T PT3813832T PT 3813832 T PT3813832 T PT 3813832T PT 197335201 T PT197335201 T PT 197335201T PT 19733520 T PT19733520 T PT 19733520T PT 3813832 T PT3813832 T PT 3813832T
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- preventing
- treating cancer
- cancer
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382485.3A EP3586847A1 (en) | 2018-06-29 | 2018-06-29 | Compounds for use in preventing or treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3813832T true PT3813832T (pt) | 2023-02-03 |
Family
ID=62842045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT197335201T PT3813832T (pt) | 2018-06-29 | 2019-07-01 | Compostos para utilização na prevenção ou tratamento de cancro |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP3586847A1 (pt) |
| JP (1) | JP7451485B2 (pt) |
| ES (1) | ES2938412T3 (pt) |
| PT (1) | PT3813832T (pt) |
| WO (1) | WO2020002701A1 (pt) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710058B2 (en) * | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| TW200307667A (en) * | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
-
2018
- 2018-06-29 EP EP18382485.3A patent/EP3586847A1/en not_active Withdrawn
-
2019
- 2019-07-01 ES ES19733520T patent/ES2938412T3/es active Active
- 2019-07-01 WO PCT/EP2019/067557 patent/WO2020002701A1/en active Application Filing
- 2019-07-01 JP JP2021500159A patent/JP7451485B2/ja active Active
- 2019-07-01 PT PT197335201T patent/PT3813832T/pt unknown
- 2019-07-01 EP EP19733520.1A patent/EP3813832B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3813832A1 (en) | 2021-05-05 |
| JP2021530472A (ja) | 2021-11-11 |
| JP7451485B2 (ja) | 2024-03-18 |
| EP3813832B1 (en) | 2022-11-09 |
| ES2938412T3 (es) | 2023-04-10 |
| EP3586847A1 (en) | 2020-01-01 |
| US20210230150A1 (en) | 2021-07-29 |
| WO2020002701A1 (en) | 2020-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006627B (en) | Methods and compositions for treating cancer | |
| IL282663A (en) | BT1718 for use in cancer treatment | |
| HUE054548T2 (hu) | Amino-triazolopiridin vegyületek és azok alkalmazása rák kezelésében | |
| IL275949A (en) | Combined treatment for the treatment of cancer or its prevention | |
| ZA201804361B (en) | 1,3,4-thiadiazole compounds and their use in treating cancer | |
| SG11202012435UA (en) | Compositions and methods for treating cancer | |
| IL259510A (en) | 1, 3, 4-thiadiazole compounds and their use for cancer treatment | |
| SG11202010528XA (en) | Combinations for treating cancer | |
| EP3708173C0 (en) | PHARMACEUTICAL COMPOSITION COMPRISING MIRNA-3140 FOR THE TREATMENT OF CANCER | |
| EP3966208A4 (en) | COMPOUNDS AND METHODS FOR TREATING CANCER | |
| IL258644A (en) | 4,3,1-thiadiazole compounds and their use for cancer treatment | |
| ZA202007955B (en) | Ccr5 inhibitor for use in treating cancer | |
| EP3440052C0 (en) | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| IL285538A (en) | Combined therapies for use in cancer treatment | |
| IL282692A (en) | Compounds derived from madrasin, a preparation and their uses for the treatment of cancer | |
| IL276073A (en) | Combined treatment for the treatment of cancer or its prevention | |
| IL276074A (en) | Combined treatment for the treatment of cancer or its prevention | |
| IL275860A (en) | Combined treatment for the treatment of cancer or its prevention | |
| IL282948A (en) | Preparations and methods for the treatment of cancer | |
| IL278921A (en) | Combined treatments for cancer | |
| GB2592803B (en) | Compounds for use in preventing or treating athlete overtraining | |
| GB201819920D0 (en) | Cancer treatment | |
| PT3813832T (pt) | Compostos para utilização na prevenção ou tratamento de cancro | |
| GB201808631D0 (en) | Combination therapy for treating or preventing cancer |